Dr. Hari Momir Polenakovik, MD

Dr. Polenakovik practices at Dayton Children's Hospital in Dayton, Ohio, part of Dayton Children's Hospital.

Dr. Polenakovik's NPI, 1902966690, was assigned on December 11, 2006. Dr. Polenakovik graduated from University Kiril and Metodij Faculty of Medicine in 1993. Dr. Polenakovik holds Ohio license 35.074531.

Dr. Polenakovik's primary practice is Dayton Children's Hospital, at 1 Childrens Plz, Dayton, OH 45404 in Montgomery County. The practice phone is (937) 641-5509.

Dr. Polenakovik's primary practice is Dayton Children's Hospital in Dayton, Ohio, part of Dayton Children's Hospital. Dr. Polenakovik is also affiliated with Kettering Health Main Campus. The medical group on file is Kettering Health Medical Group. Dmand AI also links Dr. Polenakovik to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Polenakovik practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Polenakovik's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Polenakovik is board certified in infectious disease by the American Board of Internal Medicine. Dr. Polenakovik is licensed in Ohio.

CMS data shows 32 Medicare services from Dr. Polenakovik across 1 procedure code in 2019, for 11 Medicare patients. Medicare paid $4,657 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 11 Medicare patients who saw Dr. Polenakovik in 2024. Their average risk score is 2.26, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Polenakovik's median patient age at 46, with 48% women.

In 2024, Dr. Polenakovik wrote 510 Medicare Part D claims for 23 patients. 48% of them were for generic drugs. CMS names the drug for 320 of them, across 13 drugs with 11 or more claims each, at $3,013,603 in total drug cost. In 2023, CMS named 390 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Polenakovik for performance year 2024, reported as part of a group. Dr. Polenakovik accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 28 papers to Dr. Polenakovik, published from 2003 to 2023. 2013 was the busiest year, with 2. The most frequent topics are Anti-Bacterial Agents, Staphylococcal Infections and Cephalosporins. Dr. Polenakovik has published most often in Clin Infect Dis. Dr. Polenakovik's most frequent co-authors are Jack M. Bernstein, MD, Jonathan I. Hakim, MD and George Nsenga Mwandia, MD.

Dmand AI links Dr. Polenakovik to 1 clinical trial. Conditions studied include Severe Acute Respiratory Syndrome and Influenza, Human.

CMS Open Payments shows 14 general payments to Dr. Polenakovik from 7 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 59% of the total. Shionogi Inc paid the most, $863.

Dmand AI lists 1 award for Dr. Polenakovik, most recently CMS Stage 1 EHR in 2014.

Dr. Polenakovik graduated from University Kiril and Metodij Faculty of Medicine in 1993.

Dr. Polenakovik is in network with 19 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.